Contact:
| Media |
Investor Relations |
| Karen Pineman |
Carl Hymans |
| G.S. Schwartz & Co. |
G.S. Schwartz & Co. |
| 212.725.4500 |
212.725.4500 |
| kpineman@schwartz.com |
carlh@schwartz.com |
The Quigley Corporation to Present at NYSSA
Biotech/Specialty Pharma Conference
DOYLESTOWN, PA. - December 6, 2007 - The Quigley Corporation (Nasdaq: - QGLY),
www.quigleyco.com today announced Guy J. Quigley, President and Chief Executive
Officer and other members of senior management of the Company, will be making a
presentation at the New York Society of Security Analysts, (NYSSA) 11th Annual
Biotech/Specialty Pharma Conference in New York City on Tuesday, December 11,
2007.
The presentation will be web cast live at www.quigleyco.com on Tuesday,
December 11, 2007 at 10:55AM Eastern Time. The web cast will be archived
following the presentation and a replay may be accessed at the same link.
"We are pleased by the opportunity to provide an overview of the Company and its
operations to the financial community and our investors," said Guy Quigley, J.
Quigley, President and Chief Executive Officer.
About The Quigley Corporation
The Quigley Corporation (Nasdaq: QGLY, http://www.Quigleyco.com) is a
diversified natural health medical science company. Its Cold Remedy segment is
a leading marketer and manufacturer of the COLD-EEZE® family of lozenges, gums
and sugar free tablets clinically proven to cut the common cold nearly in half.
COLD-EEZE customers include leading national wholesalers and distributors, as
well as independent and chain food, drug and mass merchandise stores and
pharmacies. The Quigley Corporation has several wholly owned subsidiaries.
Darius International markets health and wellness products through its wholly
owned subsidiary, InnerLight Inc. Quigley Manufacturing Inc. consists of two
FDA approved facilities to manufacture COLD-EEZE® lozenges as well as fulfill
other contract manufacturing opportunities. Quigley Pharma Inc.
(http://www.QuigleyPharma.com) conducts research and development for a pipeline
of patented naturally derived chemical compounds.
Forward-Looking Statements
Certain statements in this press release are "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act of 1995 and
involve known and unknown risk, uncertainties and other factors that may cause
the Company's actual performance or achievements to be materially different
from the results, performance or achievements expressed or implied by the
forward-looking statement. Factors that impact such forward-looking statements
include, among others, changes in worldwide general economic conditions,
changes in interest rates, government regulations, and worldwide competition.
|
 |
